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Abstract
Purpose
To describe and compare patient perceived barriers and motivators and decision-making
conflict between two groups of hospitalized patients, those who receive flu vaccines and
those who do not.
Data Sources
Data collection during 2003 included extracting data from databases and mailing two
surveys to 436 discharged patients. One hundred eight (108) patients participated in the
study.
Conclusions
Top barriers included fear of side effects from vaccine (35%) and fear of contracting the
flu (30%). Top motivators for obtaining a flu vaccine included previous vaccination
(93%) and provider recommendation (62%). Barriers, motivators and patient decisional
conflict differed depending upon patient vaccination status.
Implications for Practice
Given the potential negative consequences of contracting the flu, prevention is the best strategy.
Prevention is contingent upon motivating patients to obtain an annual flu vaccine.
Recommending flu vaccinations, offering vaccinations in convenient locations free of charge and
discussing perceived barriers with patients may increase vaccinations among high-risk patients.
Helping to clarify the advantages and disadvantages from the patient’s perspective may decrease
decisional conflict and increase vaccination rates.
Key words: Vaccine Hesitancy, Barriers, Motivators, Flu Vaccine, COVID-19 Pandemic, Patient
Decision-making
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Revisiting Vaccine Hesitancy, Barriers and Motivators to Obtaining a Flu Vaccine in a New
COVID-19 Pandemic World
Health care professionals are accountable for ensuring the delivery of high quality health
care to their patients. During flu season this means they work diligently to promote flu
vaccinations, especially among their high-risk patient populations. While there is little
disagreement among health care professionals as to the benefits of annual flu vaccines, there is
disparate information, crisscrossing a number of studies, about promoting flu vaccinations. In
addition, many vaccine-promoting strategies have demonstrated a negligible impact upon
vaccination rates. This article presents research findings to facilitate health care professional
decision-making regarding strategies to improve vaccination rates. Specifically, it describes flu
vaccination barriers and motivators and patterns of decision-making among high-risk patients.
Background
Vaccine-preventable deaths due to influenza and pneumonia occur every year. Annually,
influenza and influenza complications are responsible for 10 to 40 thousand deaths in the United
States. Ninety percent (90%) of deaths occur in persons 65 years or older (“Influenza and
pneumococcal”, 2002). Influenza morbidities also account for significant numbers of outpatient
visits. Unfortunately, immunization rates for high-risk patient groups run as low as 34-50%
(“Missed opportunities”, 1997; Chan-Tack, 2001; Green, 2000).
Influenza Vaccinations
Influenza vaccines are recommended for high-risk groups including children from six to 35 months, adults 65 or greater in age, people with heart disease, lung disease, kidney disease,
diabetes and immunosuppressive diseases (“Missed opportunities”, 1997; Chan-Tack, 2001). In
addition to preventing deaths, influenza vaccines have been demonstrated to be 50% - 79%
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effective in preventing hospitalizations (Furey, Robinson & Young, 2001; “Influenza:
Immunization,” 1997). Flu vaccines have also been associated with significant reductions (17%)
in outpatient visits (Nichol et al, 1996).
As well as improving patient mobidity and mortality, significant cost savings have been
demonstrated. In one study the direct net hospital cost savings averaged $73 for vaccinated
patients, with high risk patient costs savings of $166 per patient (Nichol, Wuoerenma & von
Sternberg, 1998). Baker, McCarthy, Gurley and Yood (1998) documented up to $735 per patient
in hospital cost savings.
Various approaches have been used to increase the number of persons vaccinated for
influenza, often with minimal success. For example, Baker et al. (1998) mailed three different
types of patient reminders to three groups in order to compare responses among groups. One
group received a generic message postcard, another received a personalized postcard, and a third
group recieved a personalized tailored letter. The personalized tailored letter demonstrated only
a 45.2% vaccination rate, followed by the personalized postcard at 44.7%, generic postcard at
43.5%, and finally, a control group (no intervention) at a comparable rate of 40.6% (p<.0001).
Patient Decision-making and Influenza Vaccinations
Patients deciding to obtain a flu vaccination can be viewed as voluntarily participating in
a health-promoting behavior. However, not all patients follow advice (Davis et al. 2002; Russell,
Daly, Hughes & Hoog, 2003). According to Pender (1987) and others (Begue & Gee, 1998;
Green, 2000; “Reasons reported”, 1999; O'Connor, 1995), a number of health promotion factors
(cognitive-perceptual factors and modifying factors) lead up to the decision to actually engage in
the health promoting behavior (see Figure 1).
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Cognitive-perceptual factors. A number of cognitive-perceptual factors have been
associated with flu vaccination rates. Classifying patients into high-risk groups has historically
been important for targeting patients for vaccinations. It is assumed that if patients perceive they
are high risk they will decide to engage more frequently in health promoting behaviors. But from
a patient perspective, while there may be an awareness of the meaning of high risk, the majority
of these patients do not consider themselves personally to be a member of this group and
therefore do not self identified for flu vaccinations (Gene et al., 1992; Hutchinson & Norman,
1995). In addition, perceived lack of interest by a primary physician (Buffington & LaForce,
1991) has been a reported perceptual factor associated with lower vaccination rates.
Patient knowledge, a cognitive factor, can also affect decision-making. A Medicare
Beneficiaries patient interview study concluded, “not knowing the vaccination was needed" was
the most reported reason (barrier) for not obtaining a influenza vaccination (“Reasons reported”,
1999).
Modifying factors. Research to date provides mixed results regarding demographic
modifying factors such as gender, race and ethnicity to flu vaccine rates. For example, Black et
al. (1993) found that men were more likely to respond to a public health nurse educational
intervention than women. By contrast, Gene et al. (1992) found that male flu vaccination rates
actually decreased with personal physician recommendations.
In terms of race and ethnicity, Non-Hispanic blacks, Hispanics and other ethnic groups
(Asian and American Indian groups) had lower vaccination rates than whites, with non-Hispanic
blacks being the lowest (45.8%) (“Missed opportunities”, 1997). Baker et al.'s (1998) study also
found significant differences in vaccination rates between two ethnic groups (72.9% Non-
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Hispanic white versus 24% African American). Among seniors, only 43% of Hispanics and 50%
of Blacks were vaccinated (“Researchers examine”, 2003).
Behavioral factors such as previous experience with health promoting actions have
impacted vaccination rates. Watkins (1997) demonstrated that experience with being vaccinated
("receives vaccine each year") accounted for 40.9% of all doses given during the study period.
Moran, Nelson, Wofford, and Velez (1996) also found that a positive immunization history
contributed to increased vaccination rates (44% versus 19%).
Findings concerning interpersonal factors have been mixed. Increased vaccination rates
were demonstrated with one-to-one physician or nurse recommendations (“Researchers
examine”, 2003; Russell et al., 2003), family opinions (Gene et al., 1992), being convinced of the
seriousness of influenza by others (“Researchers examine”; Buffington & LaForce, 1991; Carter,
1992; Watkins, 1997), and personalized letter reminders from their physicians (Baker et al.,
1998). However, as previously mentioned, Gene et al (1992), did not find increased rates among
men when personalized recommendations were made by physicians.
A number of situational factors found to contribute to increased flu vaccination rates.
These comprise convenient vaccination scheduling (Begue & Gee, 1998), available health center
vaccination information (Gene et al., 1992), convenient locations to obtain vaccinations,
including home (Hughes & Tartasky, 1996), and no or low cost vaccinations among the elderly
population (Nexoe, Kragstrup, & Ronne, 1997; Satterthwaite, 1997).
Decision-making process. Patient decision-making directly affects the likelihood of
engaging in health promoting behaviors. Decisional uncertainty has been used as a model to
examine decision-making regarding obtaining flu vaccinations. Decision uncertainty, factors
contributing to uncertainty, and perceived effective decision-making have been demonstrated to
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affect the likelihood of obtaining flu vaccines (O'Connor, 1995). Additional factors contributing
to decisional conflicts include a lack of information about alternatives and consequences when
selecting alternative behaviors, unclear values, emotional distress, skill deficits in decision
making, and pressures from "important" others who are imposing conflicting views (O'Connor,
1999). Research has demonstrated "declines" in uncertainty when patients experience "declines"
in a) feeling uniformed, b) being unclear about personal knowledge, and c) feeling unsupported
in decision making. In addition, perceived effective decision-making (defined as being informed,
consistent with personal values, and acted upon) was negatively correlated to uncertainty
(Pearson r = -0.46 to -0.58).
Historically, many strategies have been attempted to increase influenza vaccination rates.
The fact remains that many people in the US do not engage in life-saving, health promoting
behaviors such becoming vaccinated for influenza. While single studies have investigated
specific strategies to promote flu vaccines with varying success rates, a comprehensive research
study has not been conducted to describe and compare motivators, barriers, and decision-making
between vaccinated and non-vaccinated high-risk patients.
Design
A descriptive comparative design was utilized to address the specific aims for this study.
Aims were to 1) describe patient flu vaccination histories; 2) describe patient perceived barriers
and motivators to obtaining flu vaccinations; 3) describe patient decision-making conflict
regarding obtaining vaccinations; and, 4) compare perceived barriers/motivators and decisionmaking conflict between patients who did and did not receive flu vaccines. The study was IRB
approved by the Internal Review Board and investigators were certified in human subjects
protection.
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Population, Sample and Setting
The high risk patient population chosen for this study were patients hospitalized with
ICD-9 codes specified by the Centers for Disease Control and Prevention for flu, pneumonia, and
upper respiratory diagnoses (382, 481, 485, 486, 3841, 4801, 4808, 4809, 4820, 4821, 4822,
4829, 4830, 4870, 5109, 5111, 5130, 48231, 48232, 48281, 48282, 48283) during a single year’s
flu season. Retrospectively, these patients represent high risk, vulnerable patient groups (“Missed
opportunities”, 1997). In otherwords, these are the patients who potentially would benefit the
most from obtaining a flu vaccine during the flu season, a target population of much interest to
NPs.
The convenience sample of 436 patients was from one not-for-profit hospital located in
Southern California. All patients discharged from this hospital with the identified ICD-9 codes
were asked to participate in the study. Data was collected in 2003.
Instruments
Two data collection instruments were utilized for this study.
Flu Vaccination Survey. The investigative team designed a survey to capture flu
vaccination barriers/motivators (see Table 1), perceived health and medical risks [i.e. , Do you
consider yourself in a high risk group (having a medical condition) needing a flu vaccine?] as
well as patient demographics (ethnicity, highest level of education, geographic location) (Cobler
& Mayo, 2002). A review of the scientific literature regarding influenza vaccination patient
barriers/motivators assisted in generating the barrier and motivator survey items. The
barriers/motivators section of survey consisted of yes/no response options. Demographic item
responses were either categorical or Likert format. Psychometric testing of the barrier/motivator
portion of this new instrument is planned for a future study.
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Decisional Conflict Scale (DCS). This instrument measured patients’ degree of
uncertainty about the course of action to take. This uncertainty can arise because of factors
inherent in the decision itself (uncertainty about the outcome and the need to make value tradeoffs between benefits and risks) and potentially modifiable factors (inadequate knowledge,
unrealistic expectations, unclear values and norms, and inadequate support).
The DCS is a 16-item scale consisting of five subscales: Certainty (Items 1- 3); Feeling
Informed (Items 4-6); Clear Values (Items 7-9); Feeling Supported (Items 10-12); and Quality of
the Decision (Items 13-16). Individual items are measured on a 5-point Likert format. Scale
anchors range from 1 (low decisional conflict) to 5 (high decisional conflict). Items are summed
and averaged. Scores of 2.0 or lower are associated with those who move to action and scores of
2.5 or greater are associated with those who delay decisions. DCS reading level is at grade 8.
The DCS has undergone extensive psychometric testing for validity and reliability. DCS
test-retest coefficients and alpha coefficients are > 0.80 (N>1000). It discriminates between those
delaying and making decisions and between decision aids and usual care interventions
(especially the Informed Subscale). Instrument testing has been done regarding a number of
decision contexts (i. e., flu vaccination, breast screening, prenatal testing, hormone replacement
therapy, treatments for lung cancer, heart disease, and atrial fibrillation). Pre and post studies that
have tested decision support interventions demonstrate change in both total scale as well as
subscales (effect size ranges from 0.40 to 1.2 for the total scale). Decision-making regarding flu
vaccines has been tested in three populations: health science students (effect size 0.82), health
care employees (effect size 0.62), and cardiac/respiratory patients (effect size 0.62) (O'Connor,
1999).

10
Methods
Mailed surveys and organizational databases generated the data for this study. Using a
hospital informational database and ICD-9 codes, data was retrieved for patient medical record
numbers, patient names and mailing addresses, diagnoses, admit and discharge dates and
comorbidities. An organizational demographic information system was used to obtain patient
age, gender, marital status, and payor.
The Flu Vaccine Survey and Decisional Conflict Scale were mailed to all 436 patients.
Data were collected on 1) patient demographics and perceived barriers/motivators regarding flu
vaccination as measured by the Flu Vaccination Survey (Cobler & Mayo, 2002) and 2) patient
decision-making conflict regarding obtaining flu vaccines as measured by the Decisional
Conflict Scale (O'Connor, 1999). Opt out postcards were included with the mailing. Patients not
returning either the survey or the postcard (indicating they did not wish to participate) within
three weeks of the mailing received a reminder phone call to complete both surveys.
Returned surveys were scanned into an Excel database and analyzed using SPSS version
11.5.0 (2002). Descriptive statistics were used to identify aggregate sample characteristics and
motivators, barriers, and decision-making.
Correlational statistics such as chi-square, phi, and Pearson's correlation were used to
describe relationships among patient characteristics, vaccination status, motivators, barriers, and
decision-making. T-tests for independent samples were used to determine differences between
the two groups of patients (vaccinated and non-vaccinated) on select study variables and DCS
subscale scores (Munro, 2001).
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Findings
A sample size of 108 patients (25%) was attained for this study (see Table 2).
Approximately half of the participants were male. The mean age was 66.3 years. While four
ethnic backgrounds were represented, the sample was predominately Caucasian (89.6%). Over
60% of the participants were either high school graduates (31.5%) or had some college (30.9%).
Self-rated health ranged from poor (12.7%) to fair (41.2%) to good (36.3%) to very good (4.9%)
to excellent (4.9%). Most patients (74.5%) believed they were in a high-risk group that would
need a flu vaccine. Current flu vaccination status reflected a disparity between self-report
(80.4%) and database (56.9%).
Barriers and Motivators
No barrier items scored above 35% for the non-vaccinated patients. Moderate to low
barriers included fear of side effects (35%) and contracting the flu from the vaccine (30%), no
provider recommendation (20%) or appointment during the flu season (20%), and egg allergy
(10%).
The top motivator for vaccinated patients was having had a vaccine in the past (93%).
Moderate motivators included provider recommendation (62%), convenient access in medical
office (56%) and vaccines available at no cost (34%). Recommendations from friends or
relatives (8%) and the media (13%), postcard reminders (9%) as well as convenient non-medical
locations (2%) were low motivators.
Barriers and motivators were associated with current flu vaccination status. Moderate
negative relationships were demonstrated between being afraid of getting sick (Phi –0.550, p =
0.000) as well as contracting the flu (Phi –0.506, p = 0.000) and being currently vaccinated.
However, a strong relationship was found between flu vaccine history and being currently
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vaccinated (Phi 0.77, p = 0.000). Moderate relationships were found between provider
recommendations (Phi 0.494, p = 0.000) as well as location convenience (Phi 0.457, p = 0.000)
and being currently vaccinated.
Patient Decisional Conflict
Overall, the non-vaccinated group scored higher on the total measure for decision-making
conflict (M = 2.13 versus 1.50) (higher score indicates more conflict). Patient decisional conflict
subscale scores differed significantly between the vaccinated and non-vaccinated patients (see
Table 3). For the non-vaccinated group, certainty (M = 2.56) and feeling informed (M = 2.17)
were the highest subscale scores. For the vaccinated group, certainty (M = 2.23) and feeling
supported (M = 1.61) were the highest subscale scores. Differences in the mean subscale scores
between the two groups ranged from 0.73 to 0.33. Overall scale reliability (alpha) for the entire
sample of patients was high at 0.9291.
Patient Characteristics, Vaccination Status and Decision-making Conflict
Vaccinated (n = 82) versus non-vaccinated (n = 26) patient groups differed on patient
characteristics; however, the groups were only significantly different on four patient
characteristics. These characteristics were age, high-risk group classification, education, and selfreport health rating. Vaccinated patients were older than non-vaccinated patients with a mean
difference of 25.84 years (p < 0.000) (see Table 4). A greater percentage of vaccinated patients
compared to non-vaccinated patients classified themselves in a high-risk group (85.4% versus
30.0%; p < 0.000) (see Table 4). Greater percentages of vaccinated compared to non-vaccinated
patients were high school (37.8% versus 7.7%), college (11.0% versus 0%), and postgraduate
(12.2% versus 7.7%) educated (p = 0.025) (see Table 5). The non-vaccinated group rated their
over all health higher than the vaccinated group (p = 0.002) (see Table 6). There were no
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significant differences between the two groups of patients in terms of gender, mean length of
stay (LOS), ethnicity, geographic location (zip code), or admission diagnoses.
Study Limitations
Limitations of the study included that fact that while the overall sample was considered
adequate, the samples for examining some associations between variables were not adequate.
Therefore, it is recommended that the study be replicated using a larger sample with a stratified
sampling plan.
Conclusions
Only 76.9% of the high-risk, hospitalized patients self-reported as having been
vaccinated during the flu season. For a high-risk patient population, this is too few. Adding to
this concern is that the organization’s database only could account for 53.7% of the study
patients as having been vaccinated. While more study is needed to identify why there are
differences between self-reports and institutional database reports, neither percentage is
acceptable for a high-risk patient population. However, to put these numbers into perspective, the
percentages are higher than reported by other studies (Chan-Tack, 2001; “Missed opportunities,”
1997).
While testing a theoretical model for patient decision-making was not the aim of this
study, Figure 1 will be utilized to further discuss the study’s findings. This theoretical model
helps to organize barrier, motivator, decision-making, and demographic study variables and
relate each of them to the end point, obtaining a flu vaccine. For the purpose of this discussion,
individual demographic characteristics, barrier and motivator findings will be classified as either
cognitive-perceptual or modifying factors. Findings from the DCS will be discussed in terms of
decision-making processes.
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Cognitive-perceptual Factors
Cognitive-perceptual factors include perceived high-risk classification, patient knowledge
deficits, and perceived lack of provider interest. The majority of patients in the study perceived
themselves to be in a high-risk group. This finding is different from other studies where the
majority of patients do not perceive themselves to belong to this group (Gene, et al, 1992;
Hutchinson & Norman, 1995). So, patients in this study who perceived they were in a high-risk
group and who ranked their overall health as only fair to poor were vaccinated.
Like other work (Begue & Gee, 1998), fear of side effects and contracting the flu from
vaccines, both based on knowledge deficits, were barriers to obtaining vaccines in this study. In
other words, myths about flu vaccines are alive and well. Interestingly, media recommendations,
commonly used in the fall seasons to inform the public about the need for flu vaccines was not a
top motivator in this study.
Additionally, postcard reminders from providers, which might demonstrate provider
interest in patient well-being, were not top motivators. Most importantly, no recommendation
(perceived lack of provider interest) was associated with lower rates of vaccinations among the
patients.
Modifying Factors
Modifying factors include patient demographics, behavioral factors, interpersonal
relationships, and situational factors. In terms of patient demographics, older patients or those
having more education were more likely to be vaccinated. More vaccinated patients also had
obtained a flu vaccine in the past, an important behavioral factor. Other studies support this
behavioral finding (Moran, et al., 1996; Watkins, 1997). Interestingly, interpersonal relationships
with family and friends were not prominent modifying factors.
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On the other hand, situational factors, such as sites conveniently located in medical
offices and free vaccinations were top motivators. However, common strategies used to increase
vaccination rates such as non-medical locations (including homes, shopping centers, and
churches) were not top motivators.
Decision-making Processes
Patient decision-making conflict regarding obtaining vaccinations was measured in terms
of certainty/uncertainty, value clarity, and presence and quality of support. Overall, nonvaccinated patients were less certain about their decision than vaccinated patients. Vaccinated
patients had less conflict in terms of being certain about their decisions. The vaccinated group
also felt more informed and supported. They had less conflict in terms of their values and rated
the quality of their decision higher than the non-vaccinated group.
Recommendations
Busy health care professional schedules necessitate that they prioritize how they spend
their time. This study demonstrated that patients with a history of flu vaccines continue to obtain
the vaccines. Therefore, health care professionals need to know which patients do not have a
history of flu vaccines and work with those patients. These professionals should also be targeting
younger and less educated (high school and less) patients as these groups tended to be the nonvaccinated patients in this study.
Since patients perceiving themselves as high risk are obtaining flu vaccines, the key then
would be to assess each patient’s understanding of their status. Those who do not perceive
themselves as being high risk would get some additional intervention time with the health care
professional in order to bring about a different self-perception.
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Some barriers and motivators are within the direct control of health care professionals
and others represent system level issues. More in their direct control, health care professionals
should be recommending flu vaccines because over half of the patients indicated this was a
motivator. These professionals should also be discussing patient fears and myths around side
effects and contracting the flu from vaccinations. These discussions may help to decrease
decisional conflict and thereby increase vaccination rates.
System level issues may require more indirect and long term strategies on the part of
health care professionals. For example, in staff meetings nurses and physicians should be
advocating for their patients to the health care system in terms of vaccinations being
conveniently located within the medical office buildings, routinely administered during
appointments, and free of charge.
Overall, non-vaccinated patients were less certain about their decisions than vaccinated
patients. This indicates that health care professionals have opportunities to impact the decisionmaking of these non-vaccinated patients. In other words, they should make an effort to continue
to be proactive in providing information, dispelling myths, and removing barriers.
All health care professionals should realize that the negative myths and legends about flu
vaccines are alive and well among high-risk patients. Patient perceptions are driving patient
behaviors, including decisions to not obtain flu vaccinations. Health care professionals can
educate their fellow coworkers to this fact and encourage everyone to discuss perceived barriers
with their patients to clarify misconceptions.
Given the potential negative consequences of contracting the flu, prevention is the best
strategy. Prevention is contingent upon motivating patients to obtain an annual flu vaccine. The
findings from this study highlight the important role health care professionals have in medical
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offices and acute care settings as the front line “motivator” when it comes to promoting flu
vaccinations among high-risk patients during the flu season. Patients follow the
recommendations of their providers to obtain flu vaccines.
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Table 1 Motivators and Barriers
Motivators

Barriers

Past personal practice of obtaining vaccine

Fear of needles

annually

Fear of contracting flu

Provider recommendation

Fear of becoming ill from vaccine

Media recommendation

No recommendations to obtain the vaccine

Relative or friend recommendation

Unable to obtain the vaccine

Post card reminder

Unable to get to a vaccination location

Close contact with others with flu

Inconvenient location

Convenient location

No appointment with provider during flu

No charge for vaccine

season
Cost
Too ill
Pregnant & thought could not receive vaccine
Allergy to eggs
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Table 2 Respondents’ Characteristics (N=108)
Characteristic
Age (in years)
Gender
Male
Female
Ethnicity
Caucasian
Hispanic
Asian/ Pacific Islander
Black/ African American
Highest Level of Education
Less than high school
High school graduate
Some college
College graduate
Post graduate
Self-rated Health
Poor
Fair
Good
Very good
Excellent
High risk group needing vaccine
Yes
No
Not sure
Self-report vaccination status
Vaccinated
Not vaccinated

Mean (SD)
66.3 (22.17)

Range
2-95

% (n)

50.9 (55)
49.1 (53)
89.6 (86)
11.8 (7)
11.8 (2)
1.0 (1)
11.7 (11)
31.5 (33)
30.9 (29)
11.8 (9)
12.8 (12)
12.7 (13)
41.2 (42)
36.3 (37)
11.8 (5)
4.9 (5)
74.5 (76)
13.7 (14)
11.8 (12)
75.9% (82)
24.1% (26)
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Table 3 Patient Decision-making Conflict (N=108)
Sub Scales

Vaccinated
Non-Vaccinated
Mean Score (SD)
Mean Score (SD)
Certainty
2.23 (0.66)
2.56 (0.58)
Feeling Informed
1.51 (0.60)
2.17 (1.01)
Clear Values
1.47 (0.57)
2.11 (0.86)
Feeling Supported
1.61 (0.63)
2.06 (0.81)
Quality of Decision
1.46 (0.64)
2.13 (0.80)
Total Scale
1.50 (0.54)
2.13 (0.80)
*p< 0.05
**p<0.01
Overall scale reliability (alpha) = 0.9291

t-test
-1.996* df 93
-2.752* df 91
-3.022** df 90
-2.545* df 89
-2.968** df 88
-3.219** df 92
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Table 4 Vaccinated versus Non-vaccinated group comparisons by patient characteristics (age,
gender, perceived high risk group classification, mean LOS) (N=108)
Patient
Characteristic
Age Group
Gender
Perceived
High Risk
Group
Classification
Mean LOS1
1
2

Vaccinated
Mean rank 56.57

Non-Vaccinated
Mean rank 30.73

M 48.8% (40)
M 65.0% (13)
F 51.2% (42)
F 35.0% (7)
Yes 85.4% (70)
Yes 30.0% (6)
No 6.1% (5)
No 45.0% (9)
Not sure 8.5% (7) Not sure 25.0% (5)
6.10 Days

Length of stay
Level of Significant (p value)

5.30 Days

Test Value

Sig2

Man Whitney U
404.5
X2
1.695 df 1
Cramer’s V
0.525

0.000

t-test
0.739 df 100

0.462

0.193
0.000
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Table 5 Vaccinated versus Non-vaccinated group comparisons to education (N=108)
< High
School
% (n)
9.8% (8)

High
School
% (n)
37.8% (31)

Vaccinated
(n=82)
Non11.5% (3)
7.7% (2)
vaccinated
(n=26)
Cramer’s V 0.344; p = 0.025

Some
college
% (n)
23.2% (19)
38.5% (10)

College
% (n)
11.0% (9)

Post
graduate
% (n)
12.2% (10)

No
response
% (n)
6.1% (5)

0% (0)

7.7% (2)

34.6% (9)

27
Table 6 Vaccinated versus Non-vaccinated group comparisons to self-reported health rating
(N=108)
Excellent
Very
Good
Fair
Poor
No
% (n)
Good
% (n)
% (n)
% (n)
response
% (n)
% (n)
Vaccinated
1.2% (1)
3.7% (3) 35.4% (29) 43.9% (36) 15.9% (13)
0% (0)
(n=82)
Non15.4% (4)
7.7% (2) 30.8% (8) 23.1% (6)
0% (0) 23.1% (6)
vaccinated
(n=26)
Cramer’s V 0.407; p = 0.002
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Figure Caption
Figure 1. Theoretical decision-making model for obtaining a flu vaccination based upon
available literature.
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